The present invention relates to substantially crystalline and solid state forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide (Form A-HCl, Form B, Form B-HCl, or any combination of these forms), pharmaceutical compositions thereof, and methods of treatment therewith.本發明係關於實質性結晶及固態形式之N-(4-(7-氮雜雙環[2.2.1]庚烷-7-基)-2-(三氟甲基)苯基)-4-酮基-5-(三氟甲基)-1,4-二氫喹啉-3-甲醯胺(形式A-HCl、形式B、形式B-HCl、或該等形式之任一組合)、其醫藥組合物、及使用其進行治療之方法。
